- Home
- FSM vs TMDX Comparison
FSM vs TMDX Comparison
Compare FSM & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSM
- TMDX
- Stock Information
- Founded
- FSM 1990
- TMDX 1998
- Country
- FSM Canada
- TMDX United States
- Employees
- FSM N/A
- TMDX N/A
- Industry
- FSM Precious Metals
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FSM Basic Materials
- TMDX Health Care
- Exchange
- FSM Nasdaq
- TMDX Nasdaq
- Market Cap
- FSM 2.0B
- TMDX 2.3B
- IPO Year
- FSM N/A
- TMDX 2019
- Fundamental
- Price
- FSM $5.70
- TMDX $111.50
- Analyst Decision
- FSM Hold
- TMDX Buy
- Analyst Count
- FSM 1
- TMDX 10
- Target Price
- FSM $7.00
- TMDX $122.89
- AVG Volume (30 Days)
- FSM 14.5M
- TMDX 1.2M
- Earning Date
- FSM 05-07-2025
- TMDX 05-08-2025
- Dividend Yield
- FSM N/A
- TMDX N/A
- EPS Growth
- FSM N/A
- TMDX N/A
- EPS
- FSM 0.51
- TMDX 1.41
- Revenue
- FSM $1,151,277,000.00
- TMDX $488,227,000.00
- Revenue This Year
- FSM N/A
- TMDX $25.33
- Revenue Next Year
- FSM N/A
- TMDX $20.53
- P/E Ratio
- FSM $11.12
- TMDX $79.36
- Revenue Growth
- FSM 32.69
- TMDX 64.43
- 52 Week Low
- FSM $3.86
- TMDX $55.00
- 52 Week High
- FSM $6.78
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- FSM 44.91
- TMDX 78.52
- Support Level
- FSM $5.82
- TMDX $92.49
- Resistance Level
- FSM $6.26
- TMDX $95.71
- Average True Range (ATR)
- FSM 0.30
- TMDX 4.79
- MACD
- FSM -0.09
- TMDX 0.81
- Stochastic Oscillator
- FSM 33.48
- TMDX 71.36
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.